Machine learning and deep learning in glioblastoma: a systematic review and meta-analysis of diagnosis, prognosis, and treatment.
Journal:
Discover oncology
Published Date:
Aug 7, 2025
Abstract
INTRODUCTION: Glioblastoma (GBM) is the most malignant primary brain cancer, associated with a median overall survival of 15 months. Traditional diagnosis and prognosis heavily rely on clinical examination and histological investigation, both of which are subjective and time-consuming. advances in machine learning (ML) and deep learning (DL) have largely accelerated the research of GBMs by enhancing tumour segmentation, molecular characterization and survival prediction.
Authors
Keywords
No keywords available for this article.